LMAT vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

LMAT

47.3
AI Score
VS
LMAT Wins

XRAY

44.3
AI Score

Investment Advisor Scores

LMAT

47score
Recommendation
HOLD

XRAY

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LMAT XRAY Winner
Forward P/E 25.5754 6.3291 XRAY
PEG Ratio 2.131 0.633 XRAY
Revenue Growth 9.6% -4.1% LMAT
Earnings Growth 22.6% 15.2% LMAT
Tradestie Score 47.3/100 44.3/100 LMAT
Profit Margin 25.0% -15.0% LMAT
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LMAT 1M: -3.2% · 3M: -23.7% XRAY 1M: -23.4% · 3M: -29.8%

Current Technical Phase

LMAT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.5%), weak momentum, RSI 40

RSI (14): 40.2 · Price: $79.11

XRAY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.3%), weak momentum, RSI 28

RSI (14): 27.5 · Price: $8.65

Fundamentals Snapshot

Metric LMAT XRAY
Market Cap — —
Forward P/E 25.2 5.8
Trailing P/E 28.9 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.7% 0.5%
Operating Margin 0.3% 0.1%
EPS 2.86 -2.69
Dividend Yield 0.01% 0.04%

Frequently Asked Questions

Based on our detailed analysis, LMAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.